Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopenia
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic Advances in Hematology"
DOI: 10.1177/2040620719837906
Abstract: Primary immune thrombocytopenia (ITP) is a bleeding disorder that conventionally has been treated with steroids or other immunosuppressive treatments. The introduction of thrombopoietin receptor agonists (TPO-RAs), which increase platelet production, dramatically changed the treatment landscape… read more here.
Keywords: alternate tpo; tpo; primary immune; immune thrombocytopenia ... See more keywords